Stem Cell Banking Market to Surpass US$ 7.7 Billion by 2025 - Coherent Market Insights

Published On : Feb 28, 2018

The Global Stem Cell Banking Market, by Source Type (Cord Blood and Cord Tissue), by Service Type (Collection and Transportation, Processing, Analysis, and Storage), by Application (Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 1,634.7 million in 2016 and is projected to exhibit a CAGR of 18.9% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. The stem cell banking market is expected to gain significant traction, owing to increasing awareness regarding use of cord blood and cord tissue stem cells in therapeutics, coupled with increasing application of stem cells in the treatment of autism, lymphoma, anemia and others.

Increasing survival rate of patients post stem cell transplant is expected to augment growth the stem cell banking market

Increasing use and applications of stem cells for treatment of patients diagnosed with blood-related cancers is a major factor propelling growth of the stem cell banking market. According to the Leukemia and Lymphoma Society, 2017, an estimated 172,910 people in the U.S. were diagnosed with leukemia, lymphoma or myeloma in 2017 thus, leading to increasing adoption of stem cells for efficient treatment. Furthermore, according to the research study by Journal of Clinical Oncology, 2013, stem cell transplants for elderly patients with blood cancers are safe and effective and showed better outcome with reduction in post-transplant complications such as graft-versus-host disease by 37%. The study also stated that the survival chance after a year of stem cell transplant was around 42% and the overall survival rate was also estimated to be 55%.

Moreover, launch of innovative products and treatment therapies such as allogenic cord-blood derived hematopoietic stem cell therapy is another factor bolstering the market growth. For instance, in 2011, the FDA approved Hemacord—the first FDA-licensed hematopoietic progenitor cells-cord (HPC-C) cell therapy manufactured by New York Blood Center, Inc. Hemacord uses cord blood stem cells to treat certain disorders of the hematopoietic or blood forming system. Also, in 2014, Hemacord was awarded as Best Biotechnology Product Award by Prix Galien USA.

Browse 36 Market Data Tables and 24 Figures spread through 148 Pages and in-depth TOC on “Stem Cell Banking Market”- Global Forecast to 2025, by Source Type (Cord Blood and Cord Tissue), by Service Type (Collection and Transportation, Processing, Analysis and Storage), by Application (Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the stem cell banking market, click the link below:

Manufacturers are focusing on regenerative medicine research for harnessing the potential of umbilical cord blood stem cells for use in treating diseases and conditions that have no known cure. Manufacturers are also collaborating with academic researchers to help expand the potential uses of newborn stem cell therapies that may be available to patients and their families. For instance, in February 2018, the Institute of Integrative Biology collaborated with Anika Therapeutics, Inc., to develop an injectable mesenchymal stem cell (MSC) therapy for the treatment of osteoarthritis. Moreover, in 2016, Axiogenesis AG and Metrion Biosciences Ltd., collaborated to validate, optimize, and commercialize induced pluripotent stem cell-derived cells and tissues to speed up research in drug discovery. Also, in 2015, MAG Pharmaceuticals, Inc. acquired Cord Blood Registry (CBR)—an umbilical cord blood stem cell collection and storage company—for US$ 700 million, to expand and diversify its maternal health business.

Key Takeaways of the Stem Cell Banking Market:

  • The global stem cell banking market is expected to exhibit a CAGR of 18.9% over the forecast period, owing to rising demand for personalized medicine in Asia Pacific, Europe, Latin America, and Middle East and the benefits offered such as low risk immune rejection
  • Among source type, cord blood segment holds a dominant position in the stem cell banking market, owing to the ability of cord blood stem cells to treat over 80 blood-related diseases such as sickle cell anemia and thalassemia and various types of cancers such as leukemia and myeloma.
  • Among applications, lymphoma segment hold a dominant position in the stem cell banking market, owing to rising prevalence of these disorders and higher number of successful therapeutic procedures carried out to treat the condition using stem cells
  • Some of the major players operating in the global stem cell banking market are Stem Cyte, Inc., Cryo-cell International, ViaCord, Cord Blood Registry, SmartCells, Inc., LifeCell International Pvt. Ltd., Cryoviva Biotech Pvt. Ltd., Cryo Stemcell, Reliance Life Sciences, and Transcell Biolife Pvt. Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.